Renal Perfusion Assessment in the Endovascular Treatment of Renal Artery Stenosis
NCT ID: NCT05603221
Last Updated: 2022-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2020-11-04
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perfusion Assessment Using BOLD MRI and PBV in Endovascular Treatment of Peripheral Arterial Occlusive Disease
NCT05045365
Magnetic Resonance Imaging for Evaluating Kidney Function
NCT00006173
3D Time-of-Flight Magnetic Resonance Angiography in Hemodialysis Patients With Arteriovenous Fistula
NCT04312711
High-resolution Magnetic Resonance Vessel Wall Imaging of Plaques
NCT07125339
Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction
NCT06366529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endovascular Group
Patients who had successful endovascular revascularization
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients who were diagnosed with RAS by CTA, MRA, or Doppler ultrasonography
* patients who were aged 18 years or older
* patients whose intervened renal arteries were not completely occluded (confirmed by DSA)
* the stenosis percentage exceeding 70%
* patients who had uncontrolled blood pressure or impaired renal function
* paitents whose affected kidney did not have total loss of function
Exclusion Criteria
* had a history of renal transplantation or renal artery bypass surgery
* were allergic to iodine contrast medium
* had other contraindications of endovascular treatment
* contraindications of MRI examinations
* had technical failure in the endovascular treatment.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking Union Medical College Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASL and PBV in RAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.